Historically, the development of ICI in NSCLC has been based on the PD-L1 status of tumor cells, specifically, via a tumor proportion score[8], which is the percentage of viable tumor cells showing partial or complete membrane staining at any intensity. The gene discussed is CD274; the disease is non-small cell lung carcinoma.